Company intelligence / Profile preview

Palisade Bio

Carlsbad, California, United Statespalisadebio.com ↗

Ownership: Public · PALI
Employees: ~8
Development stage: Phase 2

Overview

Palisade Bio's lead candidate, PALI-2108, a prodrug PDE4 inhibitor, has completed single ascending dose (SAD), multiple ascending dose (MAD), food effect studies and first UC patient dosing in Phase 1a/b. Topline data are expected in the first half of 2025. The company also has a program targeting fibrostenotic Crohn’s disease at the discovery/early clinical stage. Both programs aim to address unmet needs in immune-mediated inflammatory and fibrotic diseases by improving efficacy and safety over existing therapies through precision targeting.

Therapeutic areas: Gastroenterology
Modalities: Small molecules (prodrug PDE4 inhibitors)
Industry: Biotech

Drug pipeline

4 assets

PALI-2108

3 more assets in the full pipeline.

Request access →

Partnerships

Giiant Pharma Inc. (research collaboration and license agreement)Regents of the University of California (license agreement)Newsoara Biopharma Co., Ltd. (co-development and distribution agreement)

Financials

Market cap: $355.8M
Total revenue: $500K
Enterprise value: $230.7M

Beyond the preview

Go deeper on Palisade Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Palisade Bio.

Explore the full profile